Stock Details
AMGN is Amgen Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 241.20$. Average daily volumn in 3 months 2.61M. Market cap 120.57B



Stock symbol : AMGN. Exchange : NasdaqGS. Currency : USD
Lastest price : 225.40$. Total volume : 2.54M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Amgen Inc. (AMGN)
Last Price
225.40$
Change
-3.01
Volume
2.54M

Previous Close228.41
Open228.42
Day Range225.17-230.00
Bid225.28 x 800
Ask231.36 x 800
Volume2.54M
Average Volume2.61M
Market Cap120.57B
Beta0.56
52 Week Range198.64-258.45
Trailing P/E19.17
Foward P/E12.04
Dividend (Yield %)3.44%
Ex-Dividend Date2022-08-17



Financial Details


According to Amgen Inc.'s financial reports the company's revenue in 2021 were 25.98B an increase(0%) over the years 2020 revenue that were of 25.42B. In 2021 the company's total earnings were 5.89B while total earnings in 2020 were 7.26B(-28.57%).


Loading ...



Organization

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-rel... ated events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behรงet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Market Cap:
120.57B
Revenue:
25.98B
Total Assets:
61.16B
Total Cash:
7.99B


News about "Amgen Inc."

amgen-inc-nasdaqamgn-looks-just-right-image

Amgen Inc. (NASDAQ:AMGN) Looks Just Right

Source from : YAHOO!Finance - 1 days ago

With a price-to-earnings (or "P/E") ratio of 18.3x Amgen Inc. ( NASDAQ:AMGN ) may be sending bearish signals at ...See details»


biden-administration-asks-supreme-court-to-reject-amgens-repatha-patent-appeal-image

Biden Administration asks Supreme Court to reject Amgen's Repatha patent appeal

Source from : Reuters - 10 days ago

The Biden Administration told the U.S. Supreme Court on Wednesday that it should turn down a request by Amgen Inc to review a decision that invalidated patents on its blockbuster cholesterol drug ...See details»


Amgen Inc. (AMGN) is primed for evolution with the beta value of 0.57

Source from : investchronicle - 3 days ago

Letโ€™s start up with the current stock price of Amgen Inc. (AMGN), which is $230.98 to be very precise. The Stock rose vividly during the last session to $231.87 after opening rate of $229.96 while the ...See details»


amgen inc.

Source from : Fox Business - 2 days ago

President Biden is set to lay out his vision Thursday for reducing the high cost of prescription drugs, and is expected to push Congress to pass legislation that would allow Medicare to negotiate ...See details»


Amgen Inc.: Diving Into the Drug Pricing Hit From the Inflation Reduction Act, Weโ€™ve Reduced Our FVEs by 2%

Source from : YAHOO!Finance - 12 days ago

Find the latest Amgen Inc. (AMGN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»


western-wealth-management-llc-has-256-million-stock-holdings-in-amgen-inc-nasdaqamgn-image

Western Wealth Management LLC Has $2.56 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)

Source from : Defense World - 6 days ago

Western Wealth Management LLC increased its holdings in shares of Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 4.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 10, ...See details»


Amgen (NASDAQ:AMGN) shareholders have earned a 7.3% CAGR over the last five years

Source from : AOL - 9 days ago

But more than that, you probably want to see it rise more than the market average. But Amgen Inc. (NASDAQ:AMGN) has fallen short of that second goal, with a share price rise of 23% over five years ...See details»


miracle-mile-advisors-llc-grows-position-in-amgen-inc-nasdaqamgn-image

Miracle Mile Advisors LLC Grows Position in Amgen Inc. (NASDAQ:AMGN)

Source from : Defense World - 7 days ago

Miracle Mile Advisors LLC increased its holdings in Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 181.0% in the second quarter, according to the company in its most recent disclosure with the Securities ...See details»


AMGN | Amgen Inc. Quarterly Balance Sheet - WSJ

Source from : Wall Street Journal - 5 days ago

1 Day AMGN -0.39% DJIA -0.43% S&P 500 -0.21% Health Care/Life Sciences 0.53% ...See details»


Review Not Warranted: SG Tells SCOTUS to Scrap Amgenโ€™s Case on Enablement Test for Biotech Patents

Source from : IPWatchdog - 7 days ago

and Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs in the CAFC case. Amgen argued that the CAFC โ€œcreated a new test for ...See details»


Autoimmune Treatment Market 2022 Statistics, Share Price, Growth Prospects, Industry Trends till 2027

Source from : MarketWatch - 3 days ago

The global Autoimmune Treatment market size was valued at USD 166698.1 million in 2021 and is expected to expand at a ...See details»


Amgen Inc. (NASDAQ:AMGN) insiders sold US$4.9m worth of stock suggesting impending weakness.

Source from : Yahoo Finance - 5 days ago

Many Amgen Inc. (NASDAQ:AMGN) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insiders are buying is usually more helpful when ...See details»


Cancer Biologics Market to record USD 34.97 Bn growth, Evolving Opportunities with Amgen Inc. and AstraZeneca Plc

Source from : Benzinga.com - 13 days ago

Monoclonal antibodies - size and forecast 2021-2026 Vaccines - size and forecast 2021-2026 Cell and gene therapy - size and forecast 2021-2026 Others - size and forecast 2021-2026 The market ...See details»


Dow Movers: AAPL, AMGN

Source from : Nasdaq - 4 days ago

And the worst performing Dow component thus far on the day is Apple, trading down 4.2%. Apple is lower by about 18.1% looking at the year to date performance. Two other components making moves today ...See details»